What You Should Know:
Reed Jobs - the son of Steve Jobs today announced the launch of his new venture capital (VC) investment fund, Yosemite, spun out from Emerson Collective Health with an oversubscribed $200M+ first close.Yosemite aims to meaningfully accelerate the technology, treatments, and standard of care that have the power to improve the health and lives of cancer patients.Composed of the Emerson Health team, Yosemite’s unique model provides no-strings-attached
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Amazon Clinic Expands Virtual Health Nationwide
What You Should Know:
Today, Amazon Clinic announced it is now available to customers in all 50 states and Washington, D.C., offering more people easy access to licensed clinicians for virtual care.Amazon Clinic is a virtual health care marketplace available to adults 18-64, that connects customers to third-party, licensed clinicians to help manage common health conditions like urinary tract infections, pink eye, and erectile dysfunction.
Amazon Clinic Background
Customers can select
Read More
S&T Researchers Developing 3D-Printed Dressings for Better Wound Care
What You Should Know:
- Missouri University of Science and Technology researchers are developing new 3D-printed hydrogel dressings to speed up and improve the healing process for patients with second-degree burns. The research team published an article covering their latest findings in the International Journal of Bioprinting in July.
- Hydrogels are typically part of the care regimen for patients with severe burns, but what separates S&T’s research from standard hydrogels is that the
Read More
CVS: Signify Health Adds In-Home Chronic Kidney Disease Testing to Offerings
What You Should Know:
- Today, Signify Health announced the addition of a new comprehensive in-home kidney health testing/evaluation as part of their diagnostic and preventive service offerings.
- This is Signify’s latest diagnostic offering for IHEs since the addition of spirometry screenings for chronic obstructive pulmonary disease (COPD) announced in the fall of 2022. The company’s growth in diagnostic and preventive services demonstrates their ability to capture a growing number of
Read More
Augmedics Acquires Surgalign’s Digital Health Assets for $900k
What You Should Know:
- Augmedics, a provider of augmented reality (AR) surgical navigation, announced it has been named the successful bidder for the digital health assets of Surgalign and Holo Surgical following a competitive auction process.
- Augmedics’s bid for the digital health assets consists of a cash purchase price of $900,000 and the assumption of certain liabilities, as set forth in the asset purchase agreement. The sale will close pending approval by the Bankruptcy
Read More
Femtech: Juno Diagnostics Shuts Down Commercial Operations
What You Should Know:
Juno Diagnostics, a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions announced it has ceased commercial operations, effective immediately. The company released a statement citing “unforeseen circumstances have led to this difficult decision, and we’re devastated that we can no longer continue our mission-driven work to support expectant mothers like you. As we wind down commercial operations,
Read More
Femtech: HerMD Raises $18M to Transform Women’s Healthcare
What You Should Know:
HerMD, a Cincinnatti, OH-based female-founded physician-led women’s health provider committed to revolutionizing women’s healthcare secures $18M in an oversubscribed Series A-1 round led by existing investor JAZZ, with participation from B-Flexion and Amboy Street Ventures. This new investment brings HerMD’s total funding to nearly $30M.Founded by Chief Medical Officer Dr. Somi Javaid in 2015, HerMD has been revolutionizing the future of women’s healthcare through
Read More
Why Digital Pathology’s Ecosystem Won’t Support AI Startups
Whilst growth in the overall digital pathology AI market is set to scale quickly, cannibalization and consolidation are expected to create headwinds for individual AI vendors. How do investors know where their money is safest?
The recent abundance of digital pathology (DP) media coverage can make it hard to remember that not too long ago, this was a market perpetually ‘lagging’ versus other digital healthcare sectors. And whilst growth has now firmly shifted to its ‘log’ phase, there are
Read More
M&A: New Day Diagnostics to Acquire the Assets of Epigenomics AG
What You Should Know:
New Day Diagnostics LLC announced it has entered into an agreement to acquire the assets of Epigenomics AG, a molecular diagnostics company focused on blood testing for the early detection of cancer.Under the terms of the agreement, New Day Diagnostics would acquire substantially all of Epigenomics AG’s assets and intellectual property. The acquisition would expand New Day Diagnostics' portfolio in the cancer diagnostics space and include proprietary biomarker
Read More
Henry Schein Medical & Medpod Launches Portable Telediagnostic Solution
What You Should Know:
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., and Medpod Inc. launches Medpac – a lightweight, portable telediagnostic solution that allows health care providers to offer comprehensive professional care regardless of location, helping to bridge the gap between remote telemedicine consultations and in-person office visits. Exclusively distributed by Henry Schein Medical, Medpac is suitable for a range of applications, including
Read More
